Lyophilization Technology
Extending its range of LYOVAC® freeze dryers, GEA now offers both integrated and standalone equipment for the production of small-scale batches and formulation or process development
The highly flexible standalone FCM 10-P freeze dryer from GEA has been designed for the production of small-scale batches and formulation/process development. Also available as a wall-mounted option, this two-chamber unit is configured to industry standards.
With a capacity of 10 kg and shelf space of 0.63 m², the FCM 10-P also benefits from easy-access doors and spare flanges for validation and/or additional equipment.
Using the same FALCO control system as the production unit, allowing direct recipe transfer during scale-up, the FCM 10-P is GLP/GMP-compliant.
Available options:

| FCM10-P | |
| Capacity | 0,63m² shelf area |
| 4 shelves | |
| 10 kg in in 24 h | |
| Possible Load | 2608 of 2R vials |
| 1352 of 6R vials | |
| 708 of 20R vials |
A combination of isolator and machine modules, VarioSys® provides a quick and flexible way to process liquid, powder or lyophilized product in vials, ampules, syringes or cartridges. Operating in a Grade C environment, filling and capping systems can be quickly and easily interchanged, reducing in both footprint and equipment costs.

GEA’s LYOVAC® industrial-scale freeze dryers are built to customer specifications and are available with production areas of 1–60 m² and condenser capacities of more than 1000 kg.

SMART LYO™ Freeze Dryers help reduce the cost of freeze drying while maintaining quality and performance, making validation and documentation easier and reducing delivery times.

LYOPLUS™ mass spectrometer is a multi-purpose measurement device for pharmaceutical freeze dryers.

ALUS® Automatic Load & Unload Systems minimize the risk of operator/product contamination while loading and unloading a freeze dryer.
GEA centrifuges enable wastewater reuse, resource recovery, and water security by turning biosolids into value in a world facing growing water scarcity.
Last year was not a year of hyped-up headlines for alternative proteins. Perhaps that is precisely why it was an important year for food biotech, the biotechnology behind everyday foods and ingredients. While the sector worked through a difficult funding environment, approvals were still granted, pilot lines set up and new platforms tested in the background. In short: headlines are turning into infrastructure. Frederieke Reiners heads GEA’s New Food business. She and her team work at the intersection of biotechnology and industrial food production. In this interview, she takes us on a world tour of food biotech in seven questions.
Pets are family – and owners expect premium, transparent and sustainable nutrition. Freeze-drying, powered by GEA technology, helps pet food makers deliver.